Disease Events (3)
- Clinic_ER_Status - Clinical estrogen receptor status (phv00420497.v1.p1)
- Clinic_PgR_Status - Clinical progesterone receptor status (phv00420498.v1.p1)
- ypCR_in_breast_and_nodes - Complete pathological response in breast and nodes (phv00420500.v1.p1)
Other (12)
- Analyte - Analyte type (phv00420493.v1.p1)
- Clinic_Method_of_HER2-positive_testing.* - Clinical method of testing HER2 positivity (phv00420496.v1.p1)
- Collection_timepoint - Collection timepoint for this sample (phv00420495.v1.p1)
- CONSENT - Consent (phv00420487.v1.p1)
- Drug_Regimen_(first_drug_regimen_-_follow-up_drug_regimen) - Drug regimen including first and follow-up drugs (phv00420499.v1.p1)
- is tumor - Tumor status of sample (phv00420494.v1.p1)
- SAMPLE_ID - Sample ID (phv00420492.v1.p1)
- SAMPLE_ID - Sample ID (phv00420491.v1.p1)
- SOURCE_SUBJECT_ID - Source subject ID (phv00420489.v1.p1)
- SUBJECT_ID - Subject ID (phv00420486.v1.p1)
- SUBJECT_ID - Subject ID (phv00420490.v1.p1)
- SUBJECT_SOURCE - Subject source (phv00420488.v1.p1)